Alnylam Pharmaceuticals Inc (ALNY)
235.95
+2.80
(+1.20%)
USD |
NASDAQ |
Jan 07, 16:00
235.80
-0.15
(-0.06%)
After-Hours: 20:00
Alnylam Pharmaceuticals Total Liabilities (Quarterly): 4.173B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc | 126.92B |
| BridgeBio Pharma Inc | 1.883B |
| Gilead Sciences Inc | 36.14B |
| Sarepta Therapeutics Inc | 2.379B |
| Regeneron Pharmaceuticals Inc | 8.116B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.205B |
| Shareholders Equity (Quarterly) | 32.35M |
| Debt to Equity Ratio | 31.64 |
| Current Ratio | 2.749 |
| Net Debt Paydown Yield | -0.00% |